Patents by Inventor Martin Lennarth Olsson

Martin Lennarth Olsson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10350268
    Abstract: Medical use of alpha-1-microglobulin (A1M) in the treatment or prophylaxis of diseases wherein oxidative stress is a responsible factor in the progress of the disease. Notably, the present invention relates to the medical use of alpha-1-microglobulin in the treatment or prophylaxis of diseases or conditions associated with the presences of free radicals and/or free haemoglobin in the subject.
    Type: Grant
    Filed: July 17, 2009
    Date of Patent: July 16, 2019
    Assignee: A1M PHARMA AB
    Inventors: Bo Åkerström, Stefan Hansson, Martin Lennarth Olsson, Magnus Gram
  • Publication number: 20110190208
    Abstract: Medical use of alpha-1-microglobulin (A1M) in the treatment or prophylaxis of diseases wherein oxidative stress is a responsible factor in the progress of the disease. Notably, the present invention relates to the medical use of alpha-1-microglobulin in the treatment or prophylaxis of diseases or conditions associated with the presences of free radicals and/or free haemoglobin in the subject.
    Type: Application
    Filed: July 17, 2009
    Publication date: August 4, 2011
    Inventors: Bo Åkerström, Stefan Hanson, Martin Lennarth Olsson, Magnus Olsson
  • Publication number: 20090186340
    Abstract: This invention relates to a series of PCR primers that will allow the simultaneous amplification of regions of the clinically significant ABO and RHD genes.
    Type: Application
    Filed: September 22, 2005
    Publication date: July 23, 2009
    Applicants: UNIVERSITY OF THE WEST OF ENGLAND, BRISTOL, UNIVERSITETSS 1 LUND, BLODCENTRALEN SKANE
    Inventors: Martin Lennarth Olsson, Jill Rosalind Storry, Neil David Avent, Tracey Elizabeth Madgett